Setting Bigger Targets For Next-Gen Vaccines
Bio Spectrum|July 2024
New vaccine platform technologies could dramatically shorten the period from research to development, clinical trials, and vaccination. Reimagining R&D approaches in vaccine design and vaccine immunology may hold the key to significantly elevate the health impact of vaccines.
Shivani Thakar
Setting Bigger Targets For Next-Gen Vaccines

Experts worldwide are adopting novel research approaches in the molecular design of vaccines, and vaccine technology platforms. India is seeing increasing interdisciplinary research, and a rise in cutting-edge technological interventions in fundamental and translational research. The time is ripe for boosting out-of-the-box R&D approaches in vaccinology. Let's explore further.

The National Institute for Allergy and Infectious Diseases (NIAID), one of the 27 institutes and centres that make up the National Institutes of Health (NIH) of the US, referred to next-generation vaccines as those with enhanced breadth of protection to variants, improved durability, and enhanced ability to block infection/transmission relative to currently approved vaccines. The Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic, describes vaccine technology platforms as technologies that are essential for rapid responses to emerging viral threats.

Essentially, vaccine platform technologies are systems that use the same basic components as a backbone but can be adapted for use against different pathogens by inserting new genetic or protein sequences. Rational vaccine design, developed using suitable vaccine technology platforms, could thus present significant advantages in immunisation.

Creating such an unprecedented disease agnostic vaccine technology platform can empower the world to be ready for future pandemics. Studies have shown that next-generation vaccines can enable a higher spectrum of protection against multiple variants, increased durability, and minimal safety concerns due to side effects while increasing their immunogenicity.

Each vaccine's utility or efficiency is determined by its formulation, adjuvants, and mode of action.

Bu hikaye Bio Spectrum dergisinin July 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Bio Spectrum dergisinin July 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

BIO SPECTRUM DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Early Diabetic Retinopathy Detection Remains a Challenge
Bio Spectrum

Early Diabetic Retinopathy Detection Remains a Challenge

The Vitreo Retinal Society of India (VRSI) and the Research Society for the Study of Diabetes in India (RSSDI) have formulated a first-of-its kind diabetic retinopathy (DR) screening guideline to help physicians and diabetologists in India educate their patients about DR.

time-read
2 dak  |
BioSpectrum India Nov 2024
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
Bio Spectrum

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum India Nov 2024
Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology
Bio Spectrum

Qiagen launches QIAcuityDx digital PCR system for clinical testing in oncology

Qiagen N.V. has announced the launch of the QIAcuityDx Digital PCR System, a pivotal addition to its digital PCR portfolio now expanding into clinical diagnostics.

time-read
1 min  |
BioSpectrum India Nov 2024
Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis
Bio Spectrum

Thermo Fisher introduces iCAP MX Series ICP-MS to simplify trace elemental analysis

Thermo Fisher Scientific Inc. has launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS).

time-read
1 min  |
BioSpectrum India Nov 2024
Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Bio Spectrum

Singleron, Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras identifies enhanced drug delivery method for eye treatments
Bio Spectrum

IIT Madras identifies enhanced drug delivery method for eye treatments

Researchers at the Indian Institute of Technology Madras (IIT-M) have demonstrated how drugs injected in the human eye can be better delivered to the target region through ‘convection caused by mild laser heating’.

time-read
1 min  |
BioSpectrum India Nov 2024
IIT Madras develops indigenous POCUS scanner for sports injury diagnosis
Bio Spectrum

IIT Madras develops indigenous POCUS scanner for sports injury diagnosis

A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-Care-Ultrasound (POCUS) Scanner for sports injury diagnosis and management.

time-read
1 min  |
BioSpectrum India Nov 2024
Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla
Bio Spectrum

Practo strengthens Board with appointment of TVG Krishnamurthy and Dr Alexander Kuruvilla

Practo has appointed two new directors to its board: TVG Krishnamurthy and Dr Alexander Kuruvilla.

time-read
1 min  |
BioSpectrum India Nov 2024
Dr R N Gupta steps in as National President of Indian Pharmaceutical Association
Bio Spectrum

Dr R N Gupta steps in as National President of Indian Pharmaceutical Association

Dr R N Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA), the oldest and largest association of pharmaceutical professionals in the country, for the term 2024 - 2026 (October 1, 2024 - September 30, 2026).

time-read
1 min  |
BioSpectrum India Nov 2024
QR678 brings medtech leader Sridhar Ranganathan to advisory board
Bio Spectrum

QR678 brings medtech leader Sridhar Ranganathan to advisory board

QR678, a pioneering company dedicated to revolutionising hair and skin science through groundbreaking research and innovative solutions, has announced the appointment of Sridhar Ranganathan to its Board of Advisors.

time-read
1 min  |
BioSpectrum India Nov 2024